| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $34.94B | +5.1% |
| Cost of Revenue | $28.85B | +1.5% |
| Gross Profit | $6.08B | +26.3% |
| R&D Expense | $982.0M | +9.6% |
| SG&A Expense | $4.63B | -4.4% |
| Operating Income | $471.0M | +151.0% |
| Pre-tax Income | $2.50B | +2021.5% |
| Income Tax | $939.0M | +173.0% |
| Net Income | $1.55B |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Inventory | $8.59B | +4.0% |
| Current Assets | $34.15B | +24.5% |
| Total Assets | $51.48B | +11.6% |
| Current Liabilities | $31.68B | +8.1% |
| Total Liabilities | $40.89B | +8.3% |
| Stockholders' Equity | $9.55B | +28.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.58B | +117.8% |
| Investing Cash Flow | -$37.0M | +95.0% |
| Financing Cash Flow | $3.65B | +995.1% |
| +454.3% |
| EPS (Basic) | $5.65 | +453.1% |
| EPS (Diluted) | $5.58 | +448.8% |